首页 | 本学科首页   官方微博 | 高级检索  
检索        

DD3mRNA在前列腺癌早期诊断中的应用现状
引用本文:蔡永洁[综述],姜书传[审校].DD3mRNA在前列腺癌早期诊断中的应用现状[J].辽宁医学院学报,2013(6):90-92.
作者姓名:蔡永洁[综述]  姜书传[审校]
作者单位:皖南医学院弋矶山医院泌尿外科,安徽芜湖241001
摘    要:摘要:DD3mRNA仅表达在正常的前列腺组织及前列腺肿瘤组织,且在前列腺癌组织中表达量显著增高,对前列腺癌的早期诊断上其特异性及敏感性要明显优于血清PSA,使用DD3基因检测使前列腺疾病患者的活检率降低了49%。DD3mRNA具有高度的前列腺癌特异性,可以减少许多不必要的前列腺穿刺活检,有着较好的临床应用前景。

关 键 词:DD3mRNA  前列腺癌  检测法

The Status of the Application of DD3mRNA in the Early Diagnosis of Prostate Cancer
Institution:CAI Yongjie, JIANG Shuchuan (Department of Urology, Yi Jishan Hospital, Wannan Medical College, Wuhu 241001 China)
Abstract:DD3mRNA was only expressed in normal prostate tissues and prostate tumor tissues, and the expression a- mount in prostate cancer tissues increased significantly. The specificity and sensitivity of DD3mRNA for the early diagnosis of prostate cancer were obviously superior to the serum PSA. The biopsy rate of prostate patients was reduced by 49% with the application of DD3 genetic test. DD3mRNA had a high degree of specificity for testing prostate cancer, and it could re- duce the unnecessary prostate biopsy, which had a good prospect for clinical application.
Keywords:DD3mRNA  prostate cancer  detection
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号